Article
MRI appearance of BRCA-associated prostate cancer.
Clinical imaging - 1 Apr 2022
Kamal Omar, Foster Bryan R, Young Daniel J, Hansel Donna E, Coakley Fergus V
Abstract excerpt
Despite advances in diagnosis and treatment, prostate cancer remains the second leading cause of cancer related mortality in men. Prognosis is variable and dependent on several clinical and genetic factors, including BRCA gene mutations. Recent clinical studies have reported that BRCA-associated prostate cancer is a more aggressive subtype with a higher probability of nodal involvement and distant metastases at...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
